AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. 

In this webinar, hosted by DDW and supported by Azenta Life Sciences, we'll help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development.

What you will learn:

• How to optimise AAV plasmid preparation
  Best practices to address unstable sequencing
• Solutions for viral packaging, storage, and indexing
• Selecting purity and fidelity assays
• Bioinformatics tools for interpreting complex 
  data
• GLP sequencing confirmation solutions
  
  Watch the webinar on-demand now!